Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
Lab tests to evaluate renal function |
Creatinine and BUN |
|
Lab tests to evaluate liver function |
AST and ALT |
|
Plasma half-life |
-Drugs duration of action -length of time it takes for med to ↓ concentration in plasma by ½ after admin -Greater half-life, longer it takes to excrete the med -Drugs with short half-lives must be given 3-4x day -Drugs with longer half-lives need only be given once daily |
|
Half-life and renal/liver disease |
Half-life ↑ & drug concentration may reach toxic levels at normal dose→ give meds less frequently OR reduce dosages |
|
CytochromeP-450 (CYP450) enzyme system (4 possible functions) |
-Promote & accelerate renal excretion of the drug (convert lipid-soluble drugs into less lipid-soluble) -Inactivate the drug (can decrease risk of toxicity) -Transform drug to a more active form (Can increase potency ex-codeine to morphine) (Can increase risk of toxicity ex- Acetaminophen to hepatotoxic metabolite) -Activate Prodrugs |
|
Additive effect |
1+1=2 Ex:one ASA and one Tylenol= relieve headache |
|
Synergistic effect |
1+1=3 Ex: combination of CNS depressants can lead to overdose |
|
Antagonistic effect |
2+2=1 Ex: Narcan for opiate OD |
|
Agonist |
Activates the receptor |
|
Antagonist |
Blocks the receptor |
|
Affinity |
Strength of a drug and its receptor site High-affinity= high-potency (if anagonist) (drugs with a high affinity are capable of producing effects at a lower dose) |
|
Intrinsic Activity |
Ability of a drug to activate a receptorupon binding; reflected in maximal efficacy. -High-intrinsic activity= high receptor activation= intense responses -Low-intrinsic activity= low receptor activation= minimal responses |
|
How many half-lives to get to therapeutic effect? |
-takesapproximately 4 half-lives to reach the drug level where the plasma therapeuticlevel is continuously maintained |
|
Loading Dose |
1 or 2 large doses given followed by maintenance doses to achieve therapeutic level. |
|
Protein-Binding (warfarin example) |
Decreases the availability of medication due to lack of recognition by receptors
-Major protein is albumin EXAMPLE -99% of warfarin is bound to albumin. ASA also binds to albumin. -ASA displaces warfarin, and puts free warfarin into the blood which increases the risk for hemorrhage |
|
Potency |
Amount of drug given to elicit an effect. A potent drug elicits an effect at a lower dose (ex levothyroxine) |
|
Efficacy |
Magnitude of maximal response that can be produced from a particular drug. Almost always more important than potency |
|
Therapeutic Index |
ED-50/LD-50=TI (closer ED is to LD, the more narrow the TI) (OTC drugs have a wide TI) |
|
First-Pass Effect |
-Phenomenon of drug metabolism whereby the concentration of a drug is greatly reduced before it reaches the systemic circulation -Greatly reduces bioavailability |
|
Alternatives to First-Pass |
suppository, intravenous, intramuscular, inhalational aerosol, transdermal and sublingual -avoid the first-pass effect because they allow drugs to be absorbed directly into the systemic circulation. |
|
Enterohepatic Recirculation |
Biliary recirculation prolongs the action of a drug. May continue for several weeks after therapy has been discontinued. |